Exploring the Potential of HIV Integrase Inhibitors as Therapeutic Agents Against HSV and HCMV: A Molecular Docking Study. [PDF]
Rao AM +6 more
europepmc +1 more source
Prevalence of acquired resistance to HIV integrase strand transfer inhibitors (INSTIs) in clinical samples from treatment-experienced patients in Chile, 2012-2023. [PDF]
Ferrer P +5 more
europepmc +1 more source
Interactive effects of morphine and the HIV integrase inhibitor, cabotegravir, in male and female mice. [PDF]
Carbajal C +10 more
europepmc +1 more source
Novel DNA Biosensing Platform for Detecting HIV Integrase for Highly Sensitive and Quantitative HIV Detection, Diagnosis, and Therapeutic Monitoring. [PDF]
Chen F +7 more
europepmc +1 more source
7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir. [PDF]
Ziegler RE +5 more
europepmc +1 more source
Corrigendum: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir. [PDF]
Ziegler RE +5 more
europepmc +1 more source
Effect of a High-Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor Cabotegravir. [PDF]
Patel P +7 more
europepmc +1 more source
Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis. [PDF]
Hutapea HML, Maladan Y, Widodo.
europepmc +1 more source
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps. [PDF]
van der Galiën R +6 more
europepmc +1 more source
HIV-1 Sub-subtype A6 Remains Susceptible to Second-Generation Integrase Inhibitors With Limited Emergence of Resistance in Vitro. [PDF]
Saladini F +11 more
europepmc +1 more source

